Image result for FDA-EMA Cluster image

WHAT: Cluster to share best practices involving patients along drug and biologic regulatory lifecycles

WHY: Broadened approach to advance and strengthen international collaboration

WHO: FDA and European Medicines Agency (EMA)

HOW:  Meet up to four times per year

  • Learn how their respective patients are engaged and involved
  • Develop common goals of expanding future patient engagement activities

LEARN


 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s